Literature DB >> 31624969

Do replicable profiles of multimorbidity exist? Systematic review and synthesis.

Ljoudmila Busija1, Karen Lim2, Cassandra Szoeke3, Kerrie M Sanders4, Marita P McCabe5.   

Abstract

This systematic review aimed to synthesise multimorbidity profiling literature to identify replicable and clinically meaningful groupings of multimorbidity. We searched six electronic databases (Medline, EMBASE, PsycINFO, CINAHL, Scopus, and Web of Science) for articles reporting multimorbidity profiles. The identified profiles were synthesised with multidimensional scaling, stratified by type of statistical analysis used in the derivation of profiles. The 51 studies that met inclusion criteria reported results of 98 separate analyses of multimorbidity profiling, with a total of 407 multimorbidity profiles identified. The statistical techniques used to identify multimorbidity profiles were exploratory factor analysis, cluster analysis of diseases, cluster analysis of people, and latent class analysis. Reporting of methodological details of statistical methods was often incomplete. The discernible groupings of multimorbidity took the form of both discrete categories and continuous dimensions. Mental health conditions and cardio-metabolic conditions grouped along identifiable continua in the synthesised results of all four methods. Discrete groupings of chronic obstructive pulmonary disease with asthma, falls and fractures with sensory deficits and of Parkinson's disease and cognitive decline where partially replicable (identifiable in the results of more than one method), while clustering of musculoskeletal conditions and clustering of reproductive systems were each observed only in one statistical approach. The two most replicable multimorbidity profiles were mental health conditions and cardio-metabolic conditions. Further studies are needed to understand aetiology and evolution of these multimorbidity groupings. Guidelines for strengthening the reporting of multimorbidity profiling studies are proposed.

Entities:  

Keywords:  Cluster analysis; Exploratory factor analysis; Latent class analysis; Multidimensional scaling; Multimorbidity

Mesh:

Year:  2019        PMID: 31624969     DOI: 10.1007/s10654-019-00568-5

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  80 in total

1.  Patterns and Consequences of Multimorbidity in the General Population: There is No Chronic Disease Management Without Rheumatic Disease Management.

Authors:  Daniela Simões; Fábio A Araújo; Milton Severo; Teresa Monjardino; Ivo Cruz; Loreto Carmona; Raquel Lucas
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-11-17       Impact factor: 4.794

2.  Multimorbidity in the community-dwelling elderly in urban China.

Authors:  Jiayi Gu; Jianqian Chao; Wenji Chen; Hui Xu; Zhenchun Wu; Huanghui Chen; Tingting He; Lin Deng; Ruizhi Zhang
Journal:  Arch Gerontol Geriatr       Date:  2016-09-14       Impact factor: 3.250

3.  Multimorbidity in primary care: prevalence and trend over the last 20 years.

Authors:  Annemarie A Uijen; Eloy H van de Lisdonk
Journal:  Eur J Gen Pract       Date:  2008       Impact factor: 1.904

Review 4.  Falls in cognitive impairment and dementia.

Authors:  Fiona E Shaw
Journal:  Clin Geriatr Med       Date:  2002-05       Impact factor: 3.076

5.  Patterns of comorbidity and multimorbidity in the oldest old: the Octabaix study.

Authors:  Francesc Formiga; Assumpta Ferrer; Hector Sanz; Alessandra Marengoni; Jesus Alburquerque; Ramón Pujol
Journal:  Eur J Intern Med       Date:  2012-11-24       Impact factor: 4.487

6.  Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study.

Authors:  Karen Barnett; Stewart W Mercer; Michael Norbury; Graham Watt; Sally Wyke; Bruce Guthrie
Journal:  Lancet       Date:  2012-05-10       Impact factor: 79.321

7.  Burden of multimorbidity in relation to age, gender and immigrant status: a cross-sectional study based on administrative data.

Authors:  Jacopo Lenzi; Vera Maria Avaldi; Paola Rucci; Giulia Pieri; Maria Pia Fantini
Journal:  BMJ Open       Date:  2016-12-21       Impact factor: 2.692

8.  Multimorbidity of cardiometabolic diseases: prevalence and risk for mortality from one million Chinese adults in a longitudinal cohort study.

Authors:  Dudan Zhang; Xun Tang; Peng Shen; Yaqin Si; Xiaofei Liu; Zhe Xu; Jinguo Wu; Jingyi Zhang; Ping Lu; Hongbo Lin; Pei Gao
Journal:  BMJ Open       Date:  2019-03-03       Impact factor: 2.692

9.  Defining and measuring multimorbidity: a systematic review of systematic reviews.

Authors:  Marjorie C Johnston; Michael Crilly; Corri Black; Gordon J Prescott; Stewart W Mercer
Journal:  Eur J Public Health       Date:  2019-02-01       Impact factor: 3.367

10.  Lifestyle and Socioeconomic Determinants of Multimorbidity Patterns among Mid-Aged Women: A Longitudinal Study.

Authors:  Caroline A Jackson; Annette J Dobson; Leigh R Tooth; Gita D Mishra
Journal:  PLoS One       Date:  2016-06-03       Impact factor: 3.240

View more
  19 in total

1.  Clustering of physical health multimorbidity in people with severe mental illness: An accumulated prevalence analysis of United Kingdom primary care data.

Authors:  Naomi Launders; Joseph F Hayes; Gabriele Price; David Pj Osborn
Journal:  PLoS Med       Date:  2022-04-20       Impact factor: 11.069

Review 2.  Multimorbidity.

Authors:  Søren T Skou; Frances S Mair; Martin Fortin; Bruce Guthrie; Bruno P Nunes; J Jaime Miranda; Cynthia M Boyd; Sanghamitra Pati; Sally Mtenga; Susan M Smith
Journal:  Nat Rev Dis Primers       Date:  2022-07-14       Impact factor: 65.038

3.  Multimorbidity patterns and function among adults in low- and middle-income countries: a scoping review protocol.

Authors:  Karina Berner; Nassib Tawa; Quinette Louw
Journal:  Syst Rev       Date:  2022-07-07

4.  Chronic condition clusters and associated disability over time.

Authors:  Tara C Klinedinst; Lauren Terhorst; Juleen Rodakowski
Journal:  J Multimorb Comorb       Date:  2022-04-18

5.  Clinical Outcome and Utilization Profiles Among Latent Groups of High-Risk Patients: Moving from Segmentation Towards Intervention.

Authors:  Franya Hutchins; Joshua Thorpe; Matthew L Maciejewski; Xinhua Zhao; Karin Daniels; Hongwei Zhang; Donna M Zulman; Stephan Fihn; Sandeep Vijan; Ann-Marie Rosland
Journal:  J Gen Intern Med       Date:  2021-11-03       Impact factor: 6.473

6.  Plasma metabolites to profile pathways in noncommunicable disease multimorbidity.

Authors:  Maik Pietzner; Isobel D Stewart; Johannes Raffler; Kay-Tee Khaw; Gregory A Michelotti; Gabi Kastenmüller; Nicholas J Wareham; Claudia Langenberg
Journal:  Nat Med       Date:  2021-03-11       Impact factor: 53.440

7.  Exploring the relationship between depression and different multimorbidity patterns among older people covered by long-term care insurance in Shanghai, China.

Authors:  Cancan Li; Wenjia Peng; Mengying Li; Xinghui Li; Tingting Yang; Huosheng Yan; Zijing Wang; Xianjie Jia; Zhi Hu; Ying Wang
Journal:  Psychogeriatrics       Date:  2021-11-07       Impact factor: 2.295

8.  Objectives, design and main findings until 2020 from the Rotterdam Study.

Authors:  M Arfan Ikram; Guy Brusselle; Mohsen Ghanbari; André Goedegebure; M Kamran Ikram; Maryam Kavousi; Brenda C T Kieboom; Caroline C W Klaver; Robert J de Knegt; Annemarie I Luik; Tamar E C Nijsten; Robin P Peeters; Frank J A van Rooij; Bruno H Stricker; André G Uitterlinden; Meike W Vernooij; Trudy Voortman
Journal:  Eur J Epidemiol       Date:  2020-05-04       Impact factor: 8.082

9.  Comorbidity phenotypes and risk of mortality in patients with ischaemic heart disease in the UK.

Authors:  Francesca Crowe; Dawit T Zemedikun; Kelvin Okoth; Nicola Jaime Adderley; Gavin Rudge; Mark Sheldon; Krishnarajah Nirantharakumar; Tom Marshall
Journal:  Heart       Date:  2020-04-09       Impact factor: 5.994

10.  Characteristics, service use and mortality of clusters of multimorbid patients in England: a population-based study.

Authors:  Yajing Zhu; Duncan Edwards; Jonathan Mant; Rupert A Payne; Steven Kiddle
Journal:  BMC Med       Date:  2020-04-10       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.